Non-small cell lung cancer recurrent

• A clinical trial to test if an investigational combination therapy with BNT326 and BNT327 is safe and potentially beneficial for people with … Recruiting
  2024-519344-32-00 9 2026-03-16 "Non-small Cell Lung Cancer"
• A Study of BMS-986504 in Combination with Pembrolizumab Plus Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line M … Recruiting
  2025-521511-40-00 10 2025-11-18 "metastatic non-small cell lung cancer"
• A Phase 1 Study Evaluating the Safety, Tolerability, and Efficacy of BL-B01D1 in Subjects with Metastatic or Unresectable Non-Small Cell Lun … Recruiting
  2023-506539-14-00 3 2025-05-27 "Oncology"
• A Study of Subcutaneous Nivolumab plus Intravenous Ipilimumab and Chemotherapy in Participants with Previously Untreated Metastatic or Recur … Recruitment ended
  2024-520108-25-00 4 2025-11-05 "Non-small cell lung cancer (NSCLC)"
• Taletrectinib in ROS1 Positive Lung Cancer Phase 2 Global Study Recruitment ended
  2024-516604-41-00 4 2022-08-08 "Non-small Cell Lung Cancer"
• Phase 1/2 Study of CLN-081 in Patients with Lung Cancer Recruitment ended
  2024-516532-97-00 9 2020-03-26 "Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion "
• A trial to learn how well osimertinib with savolitinib works in people with non-small cell lung cancer (NSCLC) that has gotten worse after i … Recruitment ended
  2024-512581-34-00 4 2019-10-23 "EGFRm+ and MET+, Locally Advanced or Metastatic Non Small Ce"
• eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients Recruitment ended
  2024-513454-29-00 5 2015-10-15 "Non-Small Cell Lung Cancer (NSCLC)"
• A Phase 1 Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation Ended
  2023-503223-26-00 9 2024-05-07 "Advanced Solid Tumors Harboring a KRASG12C Mutation"
• A first-in-human clinical trial in adult patients with advanced non-small cell lung cancer of a personalised therapy targeting specific muta … Ended
  2024-513060-26-00 7 2021-04-07 "Non-small cell lung cancer"
• A Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Solid Tumors Ended
  2024-513625-23-00 1 2021-03-15 "Patients with relapsed or refractory solid tumors, including"
• A multicentre phase II, open-label, non-randomized study evaluating Platinum-Pemetrexed-Atezolizumab ( Bevacizumab) for patients with stage … Ended
  2024-516201-23-00 4 2019-08-26 "Lung Cancer, NSCLC"
• A clinical trial to evaluate if CC-486 plus pembrolizumab works and is safe in patients with advanced or metastatic non-small cell lung canc … Ended
  2024-513405-31-00 4 2015-12-10 "Second-line treatment of locally advanced or metastatic non-"
• A Phase 2 Study of BMS-986315 and Nivolumab in Combination with Chemotherapy in Participants with First-line Stage IV or Recurrent NSCLC Ended
  2022-503007-22-00 4 "Non-small Cell Lung Cancer"

Showing 1–14 of 14 trials